Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage topoisomerase ii'

Search results for: 'research area dna damage topoisomerase ii'

Items 31-40 of 100

Page
per page
  1. DMAT
    A3368 DMAT
     2 Citation
    Target: Pim|CK2|HIPK2|HIPK3
    Summary: CK2 inhibitor,potent and selective
      ≥23.85 mg/mL
  2. Ellipticine
    B7382 Ellipticine
    Target: Topoisomerases
    Summary: DNA topoisomerase II inhibitor
      ≥24.6 mg/mL
  3. Nedaplatin
    B1986 Nedaplatin
    Summary: DNA synthesis inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥9.8 mg/mL
  4. Camptothecin
    A2877 Camptothecin
     1 Citation
    Target: Topoisomerases
    Summary: Topoisomerase I inhibitor,prototypic
      insoluble in H2O; insoluble in EtOH; ≥8.7 mg/mL
  5. LY2109761
    A8464 LY2109761
     4 Citation
    Summary: TβRI/II kinase inhibitor
      ≥22.1 mg/mL
  6. KN-62
    A8180 KN-62
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)|P2X Receptors
    Summary: CaM kinase II inhibitor
      ≥36.1 mg/mL
  7. 7-Ethyl-10-hydroxycamptothecin
    N2133 7-Ethyl-10-hydroxycamptothecin
    Target: Topoisomerases
    Summary: TOPO I inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
  8. Z-DEVD-FMK
    A1920 Z-DEVD-FMK
     12 Citation
    Target: Caspases
    Summary: Caspase-3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥60 mg/mL
  9. Norfloxacin
    B1801 Norfloxacin
    Target: Topoisomerases
    Summary: Topoisomerase inhibitor
      insoluble in H2O; insoluble in DMSO; insoluble in EtOH
  10. Gemcitabine
    A8437 Gemcitabine
     1 Citation
    Summary: inhibitor of DNA synthesis
      ≥11.75 mg/mL

Items 31-40 of 100

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 95item
  2. Natural Products 2item
  3. Lab Reagents 1 item
Specificity
  1. Selective 69item
Reversibility
  1. Reversible 6item
  2. Irreversible 1 item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 2item
  3. Cathepsins 1 item
  4. Histone Deacetylases (HDACs) 4item
  5. Akt 1 item
  6. PI3K 6item
  7. mTOR 4item
  8. AP-1 1 item
  9. Myosin II ATPases 1 item
  10. Chk 2item
  11. Thymidylate Synthase 1 item
  12. Pim 2item
  13. PP1 1 item
  14. PP2A 1 item
  15. MET 1 item
  16. STAT 4item
  17. Estrogen and Related Receptors 1 item
  18. EGFR 1 item
  19. Reverse Transcriptases 1 item
  20. ROCK 1 item
  21. JAK 1 item
  22. DNA-PK 6item
  23. Angiotensin AT2 Receptors 3item
  24. CFTR 1 item
  25. Topoisomerases 14item
  26. ErbB 1 item
  27. DNA Methyltransferases 2item
  28. PKC 1 item
  29. Calpains 1 item
  30. Ubiquitin-specific proteases 1 item
  31. Ca2 /calmodulin-dependent protein kinases (CaMKs) 5item
  32. USP 1 item
  33. 5-HT2 Receptors 1 item
  34. Sphingosine kinases (SphKs) 1 item
  35. PKG 1 item
  36. PKA 1 item
  37. Myosin light chain kinases (MLCKs) 1 item
  38. D1 and D5 Receptors 1 item
  39. D2 Receptors 1 item
  40. D3 Receptors 1 item
  41. 5-HT1 Receptors 1 item
  42. 5-HT7 Receptors 1 item
  43. Fatty-acid-binding proteins (FABPs) 1 item
  44. ATM/ATR 2item
  45. CK2 1 item
  46. HIPK2 1 item
  47. HIPK3 1 item
  48. HIV Integrases 2item
  49. P2X Receptors 1 item
  50. Carbonic Anhydrases 1 item
  51. BLM 1 item
  52. HSV 1 item
  53. Synthases/Synthetases 2item
  54. MAGL 1 item
  55. Histamine H1 Receptors 1 item
  56. RNA Polymerases 2item
  57. CMV 1 item
  58. Angiotensin AT1 Receptors 3item
  59. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  60. Antioxidants 1 item
  61. Cytidine deaminases 1 item
  62. PP4 1 item
  63. Dipeptidyl-peptidase II 1 item
  64. PPAR 1 item
  65. HCV polymerase 1 item
  66. PTK 1 item
  67. prolactin secretion 1 item
  68. gonadotropin release 1 item
  69. Aromatases 1 item
  70. TRPC channel 1 item
  71. ATM 1 item
  72. Sirtuin 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 2item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 1 item
  5. Bladder Cancer 2item
  6. Bladder Carcinoma 2item
  7. Bladder Diseases 1 item
  8. Breast Cancer 13item
  9. Cancer 59item
  10. Cervical Cancer 2item
  11. Cholangiocarcinoma 1 item
  12. Colon Cancer 8item
  13. Colorectal Cancer 5item
  14. Diabetes 1 item
  15. Glioblastoma 4item
  16. Glioma 1 item
  17. Hepatitis C 1 item
  18. Hepatocellular Carcinoma 2item
  19. HIV 1 item
  20. HIV Infections 1 item
  21. Inflammatory Diseases 2item
  22. Leukemia 6item
  23. Lung Cancer 3item
  24. Lymphoma 5item
  25. Melanoma 5item
  26. Multiple Myeloma 2item
  27. Myeloma 2item
  28. Neuroblastoma 1 item
  29. Non-small Cell Lung Carcinoma 1 item
  30. Ovarian Cancer 8item
  31. Pancreatic Cancer 5item
  32. Prostate Cancer 6item
  33. Renal Cell Carcinoma 1 item
  34. Sarcoma 1 item
  35. Schizophrenia 1 item
  36. Squamous Cell Carcinoma 1 item
  37. Testicular Cancer 2item
  38. Type 2 Diabetes 2item